Related Experiment Videos
Tumor differences, drug differences, treatment design differences, and effects on therapeutic outcome (degree and
1Southern Research Institute, Birmingham, Alabama 35255-5305.
Progress in Clinical and Biological Research
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect.
Cancer treatment reports·1984
Establishment of cross-resistance profiles for new agents.
Cancer treatment reports·1983
Adjuvant chemotherapy.
Cancer·1978
Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971.
Cancer chemotherapy reports·1972
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
High-throughput spheroid profiling reveals BMP-driven rewiring of glioma cell death responses.
bioRxiv : the preprint server for biology·2026
Loss of short-form Ron promotes B and T cell cooperation to prevent outgrowth of breast cancer bone metastasis.
bioRxiv : the preprint server for biology·2026
ONC201 in combination with ATR inhibitor ceralasertib exhibits potent synergy in ovarian cancer cells.
bioRxiv : the preprint server for biology·2026
Metabolic-epigenetic coupling between leucine catabolism and glycolysis drives CDK4/6 inhibitor resistance.
bioRxiv : the preprint server for biology·2026
The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple negative breast cancer tumors.
bioRxiv : the preprint server for biology·2026
Structural insights into DHODH-mediated catalysis and drug resistance.
bioRxiv : the preprint server for biology·2026